Bronchoscopic cs‐FM tied to low migration rate, allows precise SBRT delivery

22 May 2021
Stereotactic body radiation therapy or SBRT which was previously used for brain and lung cancers, could revolutionise prostatStereotactic body radiation therapy or SBRT which was previously used for brain and lung cancers, could revolutionise prostate cancer treatments

Endobronchial coil spring fiducial marker (cs-FM) is a safe and rapid procedure that results in a low migration rate and allows precise stereotactic body radiation therapy (SBRT) delivery, a study has shown. Moreover, previous irradiation of the peripheral pulmonary lesion (PPL) appears to lead to a higher migration rate.

“Currently used techniques for FM placement have many limitations; transthoracic insertion has a high risk for pneumothorax, endovascular insertion requires expertise, and dedicated angiography infrastructure and endobronchial linear‐gold FM dislocate frequently,” the authors said.

This study evaluated the safety and efficacy of cs-FM endobronchial insertion under fluoroscopy with or without radial endobronchial ultrasound (R-EBUS) assessment. The authors retrospectively assessed all consecutive patients undergoing endobronchial cs-FM placement for at least one PPL <25 mm between October 2015 and December 2019.

In case of a typical R-EBUS signal, transbronchial biopsy (TBB) of the PPL was conducted. Finally, the authors analysed PPL tracking accuracy by CyberKnife, complications, cs-FM migration rate, and procedure duration.

Fifty-two patients were treated during 55 procedures, with 207 cs-FM placements in 70 PPL. Of the 70 PPL, 65 (93 percent) were successfully tracked. R-EBUS was performed for 33 (47 percent) PPL and TBB for nine (13 percent) PPL.

Bronchospasm and other complications occurred. Migration of cs-FM happened in 16 of 207 (8 percent) cs-FM placements and was more frequent when the target was in a previously irradiated area (p=0.022). The median bronchoscopy duration for 48 procedures was 31.5 min.

“SBRT is an alternative treatment for early‐stage inoperable lung cancer,” the authors noted. “Metallic FM allow[s] to increase tumour tracking precision by CyberKnife.”

Respirology 2021;26:469-476